Fiera Capital Corp Has $729.10 Million Position in CME Group Inc. (NASDAQ:CME)

Fiera Capital Corp reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 1.0% in the 3rd quarter, Holdings Channel reports. The firm owned 3,304,319 shares of the financial services provider’s stock after selling 33,571 shares during the period. CME Group accounts for approximately 2.2% of Fiera Capital Corp’s holdings, making the stock its 11th largest position. Fiera Capital Corp’s holdings in CME Group were worth $729,098,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. Y.D. More Investments Ltd acquired a new position in shares of CME Group in the second quarter worth approximately $36,000. McClarren Financial Advisors Inc. raised its stake in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares during the last quarter. Asset Dedication LLC boosted its position in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 74 shares in the last quarter. Finally, Bank & Trust Co acquired a new position in CME Group during the 2nd quarter valued at about $76,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on CME shares. Barclays upped their price objective on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. Bank of America lifted their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. The Goldman Sachs Group increased their price objective on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a report on Tuesday, October 8th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $222.73.

Insider Buying and Selling at CME Group

In other news, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the sale, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,621 shares of company stock valued at $3,441,063. Company insiders own 0.30% of the company’s stock.

CME Group Trading Up 1.9 %

Shares of CME Group stock traded up $4.14 on Friday, reaching $226.18. The company had a trading volume of 357,192 shares, compared to its average volume of 1,912,028. The firm’s 50-day moving average price is $221.36 and its two-hundred day moving average price is $209.75. The firm has a market cap of $81.45 billion, a price-to-earnings ratio of 23.35, a P/E/G ratio of 5.61 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the firm posted $2.25 earnings per share. As a group, research analysts predict that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.03%. CME Group’s payout ratio is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.